sr141716 has been researched along with atipamezole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pitkänen, A | 1 |
| Andrade, P; Hiltunen, M; Kanninen, K; Malm, T; Natunen, T; Ndode-Ekane, XE; Nissinen, J; Pitkänen, A; Sallinen, J; Shatillo, O; Soares, JI | 1 |
| Cahill, CM; Grenier, P; Olmstead, MC; Wiercigroch, D | 1 |
1 review(s) available for sr141716 and atipamezole
| Article | Year |
|---|---|
Therapeutic approaches to epileptogenesis--hope on the horizon.
Topics: Animals; Anticonvulsants; Epilepsy; Epilepsy, Post-Traumatic; Humans; Imidazoles; Immunosuppressive Agents; Piperidines; Pyrazoles; Rats; Rimonabant; Sirolimus; Status Epilepticus; Terminology as Topic | 2010 |
2 other study(ies) available for sr141716 and atipamezole
| Article | Year |
|---|---|
Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Anticonvulsants; Axons; Body Temperature; Brain; Drug Evaluation, Preclinical; Epilepsy, Post-Traumatic; Imidazoles; Male; Motor Activity; Neuronal Plasticity; Neuroprotective Agents; Piperidines; Proof of Concept Study; Pyrazoles; Random Allocation; Rats, Sprague-Dawley; Recovery of Function; Rimonabant; Seizures; Spatial Memory | 2017 |
Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Drug Tolerance; Gliosis; Imidazoles; Injections, Spinal; Male; Morphine; Neuroglia; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Spine | 2018 |